Home/Filings/4/0001562180-19-003640
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-19-003640

CIK 0001597553other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 5:18 PM ET

Size

5.5 KB

Accession

0001562180-19-003640

Insider Transaction Report

Form 4
Period: 2019-06-21
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-06-21+6,60013,200 total
    Exercise: $47.70Exp: 2027-02-06Common Stock (6,600 underlying)
Footnotes (1)
  • [F1]On February 6, 2017, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on June 21, 2019, resulting in the vesting of the option as to 6,600 shares.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:18 PM ET
Size
5.5 KB